Speed Medical Co Valuation

Is SPMD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SPMD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SPMD's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SPMD's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SPMD?

Key metric: As SPMD is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SPMD. This is calculated by dividing SPMD's market cap by their current revenue.
What is SPMD's PS Ratio?
PS Ratio	11.1x
Sales	ج.م53.67m
Market Cap	ج.م595.61m

SPMD key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	14.3x
Enterprise Value/EBITDA	-10.3x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does SPMD's PS Ratio compare to its peers?

The above table shows the PS ratio for SPMD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	3.8x
NINH Nozha International Hospital	4.5x	n/a	ج.م1.9b
AMES Alexandria New Medical Center	7.9x	n/a	ج.م2.5b
CLHO Cleopatra Hospitals GroupE	2.6x	24.5%	ج.م11.3b
ISPH Ibnsina Pharma	0.1x	14.9%	ج.م5.6b
SPMD Speed Medical Co	11.1x	n/a	ج.م595.6m

Price-To-Sales vs Peers: SPMD is expensive based on its Price-To-Sales Ratio (11.1x) compared to the peer average (3.8x).

Price to Sales Ratio vs Industry

How does SPMD's PS Ratio compare vs other companies in the Global Healthcare Industry?

125 Companies	Price / Sales	Estimated Growth	Market Cap

125 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: SPMD is expensive based on its Price-To-Sales Ratio (11.1x) compared to the Global Healthcare industry average (1.3x).

Price to Sales Ratio vs Fair Ratio

What is SPMD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SPMD PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	11.1x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate SPMD's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.